USTR

In remarks made yesterday at the Center for Strategic and International Studies, United States Trade Representative Katherine Tai provided details regarding the White House’s new approach to the United States-China bilateral trade relationship.

​In an odd example of unintended consequences, the U.S. government still is collecting as much as 25% tariffs from Chinese manufacturers on face masks and other protective wear for U.S. health care workers on the front lines of fighting the COVID-19 pandemic.

While the USTR indicated that the September 1 tariff remains on schedule, it also noted that certain products are being removed from the tariff list “based on health, safety, national security, and other factors and will not face additional tariffs of 10 percent.”